These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2830889)

  • 1. Characterization of the antigen reactive with anti-Scl-70 antibodies and its application in an enzyme-linked immunosorbent assay.
    Juarez C; Vila JL; Gelpi C; Agusti M; Amengual MJ; Martinez MA; Rodriguez JL
    Arthritis Rheum; 1988 Jan; 31(1):108-15. PubMed ID: 2830889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of anti-Scl-70 antibodies in scleroderma: increased sensitivity of detection using purified DNA topoisomerase I from calf thymus.
    Tsay GJ; Fann RH; Hwang J
    J Rheumatol; 1990 Oct; 17(10):1314-9. PubMed ID: 2174971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
    Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
    Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Anti-Topoisomerase I Antibody Testing by Multiple-Bead, Enzyme-Linked Immunosorbent Assay and Immunodiffusion in a University Setting.
    Homer KL; Warren J; Karayev D; Khanna PP; Young A; Nagaraja V; Metzger AL; Khanna D
    J Clin Rheumatol; 2020 Apr; 26(3):115-118. PubMed ID: 30585996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay.
    Hildebrandt S; Weiner ES; Senecal JL; Noell GS; Earnshaw WC; Rothfield NF
    Clin Immunol Immunopathol; 1990 Dec; 57(3):399-410. PubMed ID: 2173985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-Scl-70 antibody (anti-topoisomerase I antibody)].
    Kuwana M; Mimori T
    Nihon Rinsho; 1999 Nov; 57 Suppl():425-7. PubMed ID: 10635873
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality?
    Mahler M; Silverman ED; Schulte-Pelkum J; Fritzler MJ
    Autoimmun Rev; 2010 Sep; 9(11):756-60. PubMed ID: 20601198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I.
    Guldner HH; Szostecki C; Vosberg HP; Lakomek HJ; Penner E; Bautz FA
    Chromosoma; 1986; 94(2):132-8. PubMed ID: 2428564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibodies against topoisomerase I (Scl-70)--comparative studies on detection with recombinant protein antigens and natural enzyme].
    Seelig HP; Schröter H; Ehrfeld H; Renz M
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):505-11. PubMed ID: 7856253
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of three methods for the detection of anti-SCL70 autoantibodies].
    Yalaoui S; Gorgi Y; Ayed K
    Ann Biol Clin (Paris); 2001; 59(5):639-42. PubMed ID: 11602398
    [No Abstract]   [Full Text] [Related]  

  • 11. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients.
    Shero JH; Bordwell B; Rothfield NF; Earnshaw WC
    Science; 1986 Feb; 231(4739):737-40. PubMed ID: 3003910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term longitudinal isotypic study of anti-topoisomerase I autoantibodies.
    Hildebrandt S; Jäckh G; Weber S; Peter HH
    Rheumatol Int; 1993; 12(6):231-4. PubMed ID: 8387225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma).
    Shoenfeld Y; Grunebaum E; Laufer M; Zurgil N; Bakimer R; Lunderschmidt A; Valentini G; Tirri G; Blank M
    Isr J Med Sci; 1996 Jul; 32(7):537-42. PubMed ID: 8756980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
    Hénault J; Robitaille G; Senécal JL; Raymond Y
    Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-topoisomerase I/Scl-70 antibody].
    Kuwana M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():545-7. PubMed ID: 20942125
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-idiotypic antibodies to topoisomerase I in serum from patients with autoimmune diseases].
    Bronshteĭn IB; Shuster AM; Gromova II; Krashuk OA; Geva ON; Alekberova ZS; Gabibov AG
    Dokl Akad Nauk SSSR; 1991; 318(6):1496-500. PubMed ID: 1655373
    [No Abstract]   [Full Text] [Related]  

  • 19. An enzyme-linked immunosorbent assay for autoantibodies against the nuclear protein Scl-70.
    Geisler C; Høier-Madsen M
    J Immunol Methods; 1985 Jun; 80(2):211-9. PubMed ID: 3925022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-topoisomerase I autoantibodies in systemic sclerosis.
    Czömpöly T; Simon D; Czirják L; Németh P
    Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.